Patents Assigned to BlackThor Therapeutics, Ine.
  • Patent number: 11103171
    Abstract: A system includes a display device, a user interface, a memory, and a control system. The memory contains machine readable medium including machine executable code storing instructions for performing a method. The control system is coupled to the memory, and includes one or more processors. The control system is configured to execute the machine executable code to cause the control system to display, on the display device, a series of questions from mental health questionnaires. The series of questions includes text and answers for each question. From the user interface, a selection of answers of each of the displayed series of questions is received from a patient. Using a Bayesian Decision List, the received selection of answers is processed to output an indication of mental health of the patient. The indication of mental health identifies a kappa opioid receptor antagonist to which the patient would likely be a higher responder.
    Type: Grant
    Filed: October 23, 2019
    Date of Patent: August 31, 2021
    Assignee: BlackThor Therapeutics, Ine.
    Inventors: Qingzhu Gao, Humberto Andres Gonzalez Cabezas, Parvez Ahammad, Yuelu Liu